send mail to firstname.lastname@example.org mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
Please verify your mobile number
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Refer & Earn
My Abhipedia Earning
Kindly Login to view your earning
The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old.
Covaxin is codenamed as BBV152. It is an inactivated virus-based COVID-19 vaccine. It was developed by Bharat Biotech in association with the Indian Council of Medical Research (ICMR). Vaccine is usually considered effective if the estimate is more than 50% with a more than 30% lower limit of the 95% confidence interval. Bharat Biotech reported the Covaxin is 64 percent effective against asymptomatic cases, 78% effective against symptomatic cases, 93% effective against severe infection while 65% effective against the Delta variant of coronavirus.
By: Brijesh Kumar ProfileResourcesReport error
Access to prime resources